Carl Goldstein, MD
Nephrology · Westfield, NJNPI 1861497315
Payments from drug & device makers
Across 24 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aurinia Pharma U.S., Inc.$80
- Lilly USA, LLC$70
- Novartis$50
- GSK$48
- Novo Nordisk$47
- Apellis Pharmaceuticals, Inc.$25
- plus $102 from 7 others
What the payments were for
- Food & beverage$421100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aurinia Pharma U.S., Inc. | 3 | $80 |
| Lilly USA, LLC | 4 | $70 |
| Novartis | 3 | $50 |
| GSK | 3 | $48 |
| Novo Nordisk | 3 | $47 |
| Apellis Pharmaceuticals, Inc. | 1 | $25 |
| Travere Therapeutics, Inc. | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $17 |
| Ardelyx, Inc. | 1 | $15 |
| Fresenius USA Marketing, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Mallinckrodt Enterprises LLC | 1 | $12 |
| Bayer | 1 | $12 |
How this compares
$421 in reported general payments places this provider in the 30th percentile of 413 nephrology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LokelmaSodium Zirconium Cyclosilicate | 59 | $46,131 |
| FarxigaDapagliflozin Propanediol | 26 | $34,210 |
| Potassium Citrate ErPotassium Citrate | 119 | $24,515 |
| VeltassaPatiromer Calcium Sorbitex | 16 | $22,587 |
| Eplerenone | 34 | $6,119 |
| Sevelamer Carbonate | 26 | $3,991 |
| EdarbiAzilsartan Medoxomil | 11 | $3,019 |
| Metoprolol Succinate | 87 | $2,340 |
| Nifedipine ErNifedipine | 36 | $2,101 |
| Doxazosin Mesylate | 56 | $1,690 |
| Cinacalcet Hcl | 26 | $1,444 |
| Indapamide | 66 | $1,125 |
| Atorvastatin Calcium | 103 | $997 |
| Allopurinol | 68 | $911 |
| Potassium Chloride | 25 | $875 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Westfield
- Danny HaddadJersey City$1.7M
- Anup PatelWest Orange$1M
- Joshua KaplanNewark$509K
- Lawrence ByrdLivingston$338K
- Devang LodhaviaVoorhees$321K
- Jeffrey FeldmanUnion$315K
- Kenneth LissEatontown$271K
- Narender GoelJersey City$181K
- Vadim FinkielsteinPrinceton Junction$139K
- Neeraj SinghNew Brunswick$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.